About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, February 12th, 2018

The QualityStocks
Daily Stock List


Mentor Capital, Inc. (MNTR)

Market Intelligence Center Alert, StreetAuthority Daily, Promotion Stock Secrets, InvestorsUnderground, Cancer Roll Up Strategy, Stockgoodies, Laissez Faire Today, BUYINS.NET, Stocks That Move, Wealth Insider Alert, Five Star Stock Picks, and Stock Profile reported previously on Mentor Capital, Inc. (MNTR), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Mentor Capital, Inc. provides mezzanine financing to leaders in the cannabis arena. The Company looks to come alongside and assist larger private medical marijuana and cannabis companies and their founders in meeting their liquidity, and financial goals, to add protection for investors, and to help incubate private cannabis companies. Mentor Capital is based in San Diego, California.

Mentor participates in the legal recreational marijuana market. Nonetheless, the Company’s favored emphasis is medical. It looks to facilitate the application of cannabis to cancer wasting, calming seizures, Parkinson’s disease, lessening ocular pressures from glaucoma, in addition to blunting chronic pain.

The Company takes a major position in the varied members of its portfolio of participating companies. However, it leaves operating control in the hands of the cannabis company founders.

Mentor Capital’s preferred involvement is with larger and private pre-IPO (Initial Public Offering) medical marijuana companies, which it can help operationally prepare for the public market and finance, sometimes working with institutional partners looking for public liquidity.

The Company transferred to the cannabis space from front-line cancer investments It still keeps only minor cancer investments. Mentor will complete the shift to the cannabis market as profitable opportunities to exit present themselves.

In March of 2017, Mentor announced that it took a $1.0 million position in the stock of GW Pharmaceuticals, Plc (GWPH). GW Pharmaceuticals is a United Kingdom (UK) based group developing a family of cannabinoid prescription medicines.

In April 2017, Mentor Capital announced that it initiated funding for its GlauCanna venture for the use of medical marijuana in the treatment of glaucoma patients. It will provide financing and business management for any commercial development and holds an 80 percent interest. Dr. Robert M. Mandelkorn holds 20 percent. In addition, he provides the medical leadership for this venture. Dr. Mandelkorn is an ophthalmologist specializing in glaucoma.

Last month, Mentor Capital announced that during January it funded an additional $900,000 into G FarmaLabs. This brings the ten month multi-investment total by Mentor into G Farma to $1.8 million, which is in addition to an earlier and separate $600,000 stock transaction.

G Farma Founder, Ata Gonzalez, said, “With Mentor’s financial support, G Farma is now expanding its extraction and bottling business to conquer the California adult use market. We have a great relationship with Mentor Capital’s executive team and I am honored that they have chosen again and again to ensure our growing brand has been and continues to be well-funded as we move into the exciting cannabis future.”

Today, Mentor Capital announced that it extended into the Colorado cannabis market with its new investment in Pueblo West Organics, LLC. Mentor Capital stated it would be pleased to make a series of cannabis centered investments with cannabis veteran and Pueblo Founder, Pat Leonard. Mentor has set up Mentor Partner II, LLC as a channel for this purpose. The initial investment is roughly $400,000 lease of a system for supercritical extraction.

Mentor Capital, Inc. (MNTR), closed Monday's trading session at $1.55, up 10.71%, on 130,856 volume with 255 trades. The average volume for the last 60 days is 270,712 and the stock's 52-week low/high is $0.45/$4.82.

Sunset Island Group, Inc. (SIGO)

MicrocapVoice, PennyStockSpy, OTCPicks, and 007 Stock Chat reported earlier on Sunset Island Group, Inc. (SIGO), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Sunset Island Group, Inc. provides consulting and advisory services to clients operating in the medical marijuana business space. The Company concentrates on providing a licensed manufacturing facility to clients for producing products, including oils and edibles. Sunset Island Group has its corporate office in San Clemente, California.

The Company’s vision is to establish a fully integrated business, which provides turnkey solutions to the medical cannabis industry. Its primary emphasis is on providing a licensed facility where companies can manufacture and produce their products. In addition, Sunset Island will provide distribution for companies via an established network of dispensaries.

Sunset Island Group earlier secured a lease on a property approved for cannabis cultivation. The Company for permits for 22,000 square feet of green house space. The expectation is that the 22,000 square feet of green house space will be able to produce up to 4,000 pounds of medical cannabis each year.

Sunset Island announced last year that it initiated development of a CBD dietary supplement product. The initial product will feature a 2-oz stress relief beverage made from highest quality legal Hemp/CBD oil and real fruit.

Sunset Island will continue to develop products that will address the demands in the worldwide dietary supplements market. This market is targeted to soon reach greater than $200 billion. The product will undergo development by a trained French Chef with more than two decades of experience in Product Development and Food Production.

Sunset Island Group is performing a retrofit to its current grow space that will considerably increase the amount of cannabis product produced with each harvest. Furthermore, the Company announced in November 2017 that it commenced an aggressive expansion of its cannabis product line.

The Company’s retro fit is two phases. Phase 1 is the retro fit of the present greenhouse operations. Phase 2 is the constructing of a new greenhouse on its bare land or retrofitting another greenhouse on the property.

The aim of the retro fit for Phase 1 is to increase the growable space in the current greenhouse to about 22,000 (with a vertical grow) with roughly 85 percent being canopy space (or around 19,000 square feet). The Company's objective is to yield 0.08-0.10 pounds per growable space and to have five harvests.

Sunset Island Group has received its temporary licenses from the State of California for Distribution, Cultivation and Manufacturing. The licenses are for Adult Use (Recreational) and Medicinal. The licenses permit Sunset Island to sell and transport its own product to dispensaries across California.

The manufacturing license allows it to start manufacturing products such as vape cartridges, edibles, as well as extracts. At present, Sunset Island is in the process of converting one of its cold storage rooms into a clean room to commence manufacturing these products.

Sunset Island Group, Inc. (SIGO), closed Monday's trading session at $2.05, up 14.53%, on 289,106 volume with 326 trades. The average volume for the last 60 days is 170,484 and the stock's 52-week low/high is $0.0647/$3.79.

The Alkaline Water Company, Inc. (WTER)

Market FN, Wall Street Mover, SmallCapVoice, OTC Markets Group, Oakshire News Bulletin, StreetAuthority Financial, Penny Stock Rumble, InvestmentHouse, Investors Insights, MicroCap Gems, Investor Spec Sheet, and The Best Newsletters reported earlier on The Alkaline Water Company, Inc. (WTER), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The Alkaline Water Company, Inc. has developed a unique, state-of-the-art, proprietary electrolysis beverage process. This process produces healthy alkaline water. The water is packaged and sold in 500ml, 700ml, 1-liter, 3-liter and 1 gallon sizes under the trade name Alkaline88®. Alkaline88's premier alkaline water is a pH balanced bottled alkaline drinking water enhanced with trace minerals and electrolytes.

The Alkaline Water Company has its headquarters in Scottsdale, Arizona. The Company lists on the OTC Markets’ OTCQB. Currently, it packages and sells its alkaline water to greater than 34,000 retail locations in all 50 states.

The design of Alkaline88 is to encourage daily consumption of Alkaline Water by way of a consumer-oriented bulk delivery system targeted at removing expensive small bottles from the distribution supply chain. The production of Alkaline88 is at an 8.8 pH, intended to attain optimal body balance.

Alkaline88 contains trace Himalayan minerals. The Alkaline Water Company incorporated 84 beneficial trace Himalayan minerals to make Alkaline88 especially unique to other pH waters. Alkaline88® ranks among the fastest-growing premium bottled water brands. Its revenue has increased more than 2,100 percent since Fiscal Year (FY) 2013.

The Company utilizes an advanced Electrochemically Activated Water (ECA) system to create 8.8 pH drinking water without the use of any chemicals. The ECA process uses specialized electronic cells coated with a variety of rare earth minerals to produce scientifically engineered water.

At present, The Alkaline Water Company has six co-packers across the nation. These have up to a combined $72 million of production capabilities. These are located within 600 miles of 95 percent of the U.S. population.

This past November, The Alkaline Water Company reported financial results for the six months ending September 30, 2017. Its Revenue for the six months ended September 30, 2017 exceeded $10 million. East Coast sales currently account for roughly 20 percent of its revenue. The Company noted that this sales activity suggests that the goal of placement in 40,000 retail locations by the end of FY 2018 will be realized.

Last week, The Alkaline Water Company announced that Alkaline88® will now be available at select retailers in a 1.5-liter bottle and a 1-liter 6-pack.

Mr. Richard A. Wright, The Alkaline Water Company’s President and Chief Executive Officer, said, “Alkaline88’s 1-gallon and 3-liter bottles are the #1 selling bulk alkaline water brand in the USA. Our retailers encouraged us to develop additional multi-serving SKUs for their Alkaline88® customers. Market data shows that the public has a preference for a 1.5-liter bottle and 6-packs. We feel both these new Alkaline88® 1.5-liter and 1-liter 6-pack SKUs address existing consumer demand and should significantly increase our sales in FY 2019.”

The Alkaline Water Company, Inc. (WTER), closed Monday's trading session at $0.95, even for the day, on 18,490 volume with 20 trades. The average volume for the last 60 days is 17,142 and the stock's 52-week low/high is $0.862/$2.04.

Aphria, Inc. (APHQF)

CFN Media Group and Cannabis Financial Network News reported earlier on Aphria, Inc. (APHQF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Aphria, Inc. is one of Canada’s lowest cost producers that produces, supplies, and sells medical cannabis. The Company’s medical cannabis products are 100 percent greenhouse grown. Aphria works to provide pharmaceutical-grade medical cannabis and leading patient care. Its dedication is to do this while balancing patient economics and returns to shareholders. Aphria is headquartered in Leamington, Ontario.

Aphria is a Health Canada Licensed Producer of medical cannabis products. The only legal access to medical cannabis in Canada is by way of Health Canada Licensed Producers. However, some Canadians still have personal production licenses. This grants them authorization to produce medical cannabis for personal use.

Aphria’s commitment is to ensuring patients receive consistent, safe, and effective medical cannabis products. Its cannabis oil products are produced employing C02 extraction methods. These methods preserve purity and ensure safety.

Aphria’s equivalency factor of cannabis oil to dried cannabis is 6:1. As a result, every 6 mL of cannabis oil is equivalent to 1 gram of dried cannabis.

The Company is in the middle of a multi-phase expansion program. Upon completion of Part II, Aphria expects that annual production capacity will reach 5,500 kilograms of dried cannabis and 9,000 liters of cannabis oil.

Aphria announced in August of 2017 that it invested $11.5 million in HydRx Farms, Ltd. (o/a Scientus Pharma). Scientus Pharma is a vertically-integrated biopharmaceutical company. It focuses on the development of drugs that target the endocannabinoid receptors throughout the body for the treatment of diseases of the brain, organs, connective tissues, and more. Scientus Pharma is one of a limited number of Licensed Dealers in Canada authorized to handle and conduct cannabinoid product.

Last week, Aphria announced that it entered into a purchase and sale agreement to sell 26,716,025 shares. This represents all its shares in Liberty Health Sciences, Inc., which are not subject to Canadian Securities Exchange (CSE) escrow requirements. Each of Michael Serruya, Simon Serruya and Jack Serruya are purchasing 80 percent of all transferred shares from Aphria individually or through an affiliate. The remaining 20 percent is being purchased by an affiliate of Delavaco Capital.

After the Transaction, Aphria retains an ownership position of 28.1 percent of the issued and outstanding shares of Liberty Health Sciences.

Mr. Vic Neufeld, Aphria’s Chief Executive Officer, said, "While I continue to believe there is tremendous opportunity in the U.S. for medical cannabis, the sale of these shares serve the best interests of our shareholders and provide additional and important capital to fund Aphria's continued growth in Canada and expand into other federally legal international markets."

Aphria, Inc. (APHQF), closed Monday's trading session at $12.4891, down 2.60%, on 531,488 volume with 2,456 trades. The average volume for the last 60 days is 1,128,692 and the stock's 52-week low/high is $3.3953/$19.869.

International Stem Cell Corp. (ISCO)

Tip.us, MissionIR, Tiny Gems, StocksToBuyNow, Marketbeat, and Serious Traders reported previously on International Stem Cell Corp. (ISCO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

International Stem Cell Corp. is a clinical stage biotechnology company. It is developing stem cell-based therapies and biomedical products. The Company’s focus is on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. International Stem Cell’s core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs).

OTCQB-listed, International Stem Cell is based in Carlsbad, California. The Company has a research facility in Oceanside, California.

The hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. They offer the potential to create the first true stem cell bank, UniStemCell™. Regarding the UniStemCell™ bank, it is the life science industry’s first collection of non-embryonic histocompatible human stem cells available for research and commercial use. The human leukocyte antigen (HLA) system represents antigens vital for transplantation.

International Stem Cell scientists have created the first parthenogenetic, homozygous stem cell line. This line can be a source of therapeutic cells for hundreds of millions of individuals of differing genders, ages, and racial backgrounds with minimal immune rejection post transplantation. A relatively small number of hpSC lines could provide enough immune-matched cells to cover a significant percentage of the world’s population.

The Company has demonstrated that ISC-hpNSC® can improve cognitive performance and motor coordination in rodents with traumatic brain injury. Additionally, ten pending patent applications encompassing internally-generated and in-licensed technologies have been issued as patents.

International Stem Cell produces and markets specialized cells and growth media for therapeutic research globally via its subsidiary Lifeline Cell Technology (Frederick, Maryland) and stem cell-based skin care products through its subsidiary Lifeline Skin Care.

Lifeline Skin Care has expanded its two core technology product lines through launching four new skincare products targeting retail and professional markets. A new patent covering small molecule technology in skin care was issued to International Stem Cell in the U.S. in 2016.

In January, International Stem Cell announced interim six-month results from the first cohort of four patients in its Phase I trial of ISC-hpNSC in Parkinson's disease (PD). Positive signals were observed in an array of measures. This includes daily living, mobility, depression, as well as compulsive disorders.

This trial is continuing. The second cohort is almost enrolled, with the third patient of four recently undergoing surgical implantation. The study will enrol 12 patients at three dosing regimens (30-70m cells).

International Stem Cell Corp. (ISCO), closed Monday's trading session at $1.51, up 7.09%, on 1,135 volume with 5 trades. The average volume for the last 60 days is 5,998 and the stock's 52-week low/high is $0.99/$2.50.

Zoom Telephonics, Inc. (ZMTP)

FeedBlitz, Marketbeat, Wall Street Mover, OtcWizard, SmallCapVoice, and OTC Picks reported on Zoom Telephonics, Inc. (ZMTP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Established in 1977, Zoom Telephonics, Inc. is a top manufacturer of cable modems and other communications products. The Company designs, produces, markets, and also supports cable modems and other communications products under the Zoom, Hayes®, and Global Village® brands. Zoom Telephonics is headquartered in Boston, Massachusetts and the Company lists on the OTCQB.

Zoom Telephonics’ products include cable modems & gateways, dial-up modems, mobile broadband modems and routers, wireless networking products, ADSL gateways, Bluetooth wireless products, wireless keyboards, and ZoomGuard wireless sensors & controls.

Furthermore, products include asymmetric digital subscriber line modems, wireless local area networking products, Voice Over IP products (VoIP), wired networking equipment, dialers and related telephony products, wireless sensors and controls, phone jacks and AC power adapters, and language-related specifics.

In May 2015, Zoom Telephonics signed an exclusive license agreement with Motorola Mobility LLC. The license agreement is for the Motorola brand in connection with consumer cable modem products. This includes cable modem bridges, cable modem/routers, and cable set-top boxes containing cable modems, for the U.S. and Canada. The agreement started on January 1, 2016 and runs through December 31, 2020.

In September 2017, Zoom Telephonics announced the signing of an amendment to its license agreement with Motorola Mobility to include the exclusive worldwide rights for the Motorola brand for consumer-grade cellular modems and gateways, DSL modems and gateways, and MoCA (Multimedia over Coax) adapters.

In addition, this amendment grants Zoom Telephonics non-exclusive worldwide rights to use the Motorola brand for consumer-grade cellular home sensors, which are products designed, marketed, and sold for use by consumers for their personal, family, or household use.

Last month, Zoom Telephonics announced that it started shipments of the Motorola MM1000. This is a bonded 2.0 MoCA Adapter produced under exclusive license from Motorola Mobility LLC.

The MM1000 utilizes a home's existing coaxial cables. This is to provide a high-speed wired Ethernet connection between a router's Ethernet LAN port and any device that has an Ethernet port. The MM1000 sends and receives data at up to 1,000 Mbps between a router or modem/router and an HDTV, computer, wireless access point, game station, DVD player, network storage device, TiVo box, or other Ethernet-capable device.

In January, Zoom Telephonics announced that it expects Revenue for Q4 ended December 31, 2017 to exceed $8 million. It expects to announce full Q4 and annual 2017 financial results this month.

Zoom Telephonics, Inc. (ZMTP), closed Monday's trading session at $2.00, even for the day, on 38,900 volume with 5 trades. The average volume for the last 60 days is 10,138 and the stock's 52-week low/high is $1.46/$2.48.

Stealth Technologies, Inc. (STTH)

NetworkNewsWire and RedChip reported previously on Stealth Technologies, Inc. (STTH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Stealth Technologies, Inc. is a technology business listed on the OTC Markets Group’s OTCQB. The Company previously went by the name Excelsis Investments, Inc. It changed its name to Stealth Technologies, Inc. in July 2016. Stealth Technologies engages in identifying and capitalizing on technology and associated markets. The Company produces products for personal and financial protection.

Incorporated in 2010, Stealth Technologies has its corporate office in Largo, Florida. It became public through a reverse merger in 2012.

Moreover, Stealth Technologies announced in March of this year the completion of five new products. Currently, these products are staged in a large direct response retailer's quality assurance and legal department. They are under final review to ensure that marketing claims associated with each product are accurate when measured against actual performance levels of each product, and that assurance and inventory is satisfactory and has met all quality control factors. Stealth Technologies’ strategic initiative is to expand its product footprint across varied industries and distributors.

The Company has developed a group of products to protect against "electronic pickpockets," emergency response latency, credit fraud protection, and cell phone data protection. Its initial product to market is the Stealth Card.

The design of the Stealth Card is to protect the Radio-Frequency Identification (RFID) chip in a consumer's credit card from electronic stealing or pickpocketing, which uses a smartphone, credit card reader, or RFID antenna to remotely access data stored on the consumer's Smartchip. Stealth Card renders the chipped information invisible to intrusion.

The Stealth Card is a 100 percent USA product. The Stealth Card is manufactured from Stealth Technologies’ laboratory and research/development facility in West Virginia to its manufacturing facility in Massachusetts.

Development for the Stealth Card started in 2012. This is when Company Founder and Chief Executive Officer (CEO), President, and Director, Mr. Brian McFadden, observed the worldwide shift towards smart chip card technology to transmit and process credit card/debit card transactions. With Europe and Asia already making the transition away from the magnetic strip to smart chip cards, Mr. McFadden believed the United States market would need to follow suit.

To use the Stealth Card, a person places a Stealth Card in their wallet, pocket, change purse or anywhere they carry their credit cards. One card can protect up to 12 cards in a wallet. The card can be physically placed anywhere in a wallet or pocket.

The card does not need to be in the front or back of one’s wallet. The Stealth Card provides effective protection irrespective of where it’s placed in relation to one’s credit cards.

In December 2016, Stealth Technologies announced the development of the 911 Help Now Generation II Product. The 911 Help Now product provides a direct two-way voice connection to emergency service providers. The 911 Help Now pendent works by pressing the Help Now button and then a person is connected.

Stealth Technologies has a number of other products under development. The Company is exploring potential military applications of its proprietary technologies.

Along with the Stealth Card and the 911 Help Now Generation II Product, Stealth Technologies’ portfolio includes Data Secure Plus, which is new to market. Its portfolio also includes Stealth Mobile.

Stealth Technologies, Inc. (STTH), closed Monday's trading session at $0.07, up 30.27%, on 100,683 volume with 13 trades. The average volume for the last 60 days is 18,020 and the stock's 52-week low/high is $0.023/$0.675.

Cadus Corporation (KDUS)

OTC Markets, InvestorsHub, Morningstar, MarketWatch, CorporateInformation, Capital Cube, The Street and Greenbackers reported on Cadus Corporation (KDUS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Cadus Corporation is in the business of buying individual homes and individual residential lots, renovating or constructing on them, and reselling them. To date, it has mainly centered its real estate activities in the State of Florida. Established in 1992, Cadus has its corporate headquarters in New York, New York. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Cadus’ portfolio includes Sunset Island II; Atlantic Island; Town of Surfside; Sans Souci Estates I; Sans Souci Estates II; Stillwater; as well as Biscaya Island. Sunset Island II features a two-story open-concept layout. It includes a spacious open kitchen, an oversized master suite, 11’6 ceilings, and a pool. It is in South Beach’s exclusive Sunset Island II gated community.

Atlantic Island is on Atlantic Isle. It is an elegant 3-bedroom new construction to-be-built waterfront home. It features a distinguished contemporary architectural design.

The Town of Surfside in Surfside Florida is a modern-style to-be-constructed home. It is set over a creative two-story open-concept layout. This includes a sleek kitchen, 11’6 ceilings, an oversized master suite, and also a family room.

Sans Souci are premier waterfront lots. They provide the setting for these to-be-built new construction masterpieces. They are open-concept homes that feature an over-sized master suite, designer finishes in the kitchen and bathrooms, and wide bay views from every angle of the homes.

Stillwater in Miami Beach, Florida, is in the gated community of Stillwater Drive in a modern to-be-built new construction home. This two-story open-concept home features designer kitchens and bathrooms. It offers wide bay and Indian Creek Island views.

Biscaya Island in Miami Beach is positioned along immaculate private waterfront on Biscaya Island. The new construction to-be-built home is crafted with a contemporary exterior and an open-concept layout.

Last month, Cadus announced that it entered into an Agreement and Plan of Merger with Starfire Holding Corporation, an affiliate of Carl C. Icahn and an affiliate of Cadus’ controlling stockholders, Barberry Corp. and High River Limited Partnership (High River collectively). Starfire will acquire Cadus.

With this Merger Agreement, upon completion of the transaction, all outstanding shares of Cadus common stock not owned by High River or its affiliates will be converted into the right to receive $1.61 per share in cash, without interest.

Cadus Corporation (KDUS), closed Monday's trading session at $1.59, up 0.55%, on 30,000 volume with 3 trades. The average volume for the last 60 days is 21,524 and the stock's 52-week low/high is $0.92/$1.59.

Bullfrog Gold Corp. (BFGC)

PennyStockLocks, StockBomb, StockLockandLoad, Wall Street Mover, PennyStocks24, TopPennyStockMovers, InvestorTrendz, Pumps and Dumps, HEROSTOCKS, and Liquid Pennies reported previously on Bullfrog Gold Corp. (BFGC), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Bullfrog Gold Corp. is a mineral exploration company listed on the OTC Markets’ OTCQB. The Company has a strong asset portfolio with large prospective gold exploration projects located in productive mining districts within the south-western United States. Bullfrog Gold principally explores for gold, silver, and other metals. Bullfrog Gold has its head office in Grand Junction, Colorado.

The Company has its Bullfrog Project. The Bullfrog Project is approximately three miles northwest of the town of Beatty and 116 miles northwest of Las Vegas, Nevada. The Bullfrog Gold Project is in the prolific Walker Trend. Barrick Gold Corp. produced 2.1 million ounces of gold during the 1990’s from the main Bullfrog open pit, the northern one third of which is presently controlled by Bullfrog Gold.

In addition, Bullfrog Gold's lands include the entire Montgomery-Shoshone (M-S) deposit, from which Barrick produced an additional 220,000 ounces of gold. Additionally, the M-S area produced 70,000 ounces averaging 0.47 gold ounce per ton from underground mining operations in the early 1900's.

Bullfrog Gold executed an option in October 2014 to purchase 12 strategic patented claims situated contiguous to its lands and that include the north-east half of the M-S open pit mine. In March of 2015, the Company exercised a lease/option to purchase 6 patented claims, 20 unpatented claims, and 8 mill site claims from Barrick Bullfrog, Inc.

The M-S and Bullfrog deposits are amenable to heap leaching. They can support a mine cut-off grade of 0.2 g/t for leaching at coarse ROM sizes. Bullfrog Gold announced in June 2017 a base case, maiden resource estimate of 525,000 ounces of gold averaging 1.02 g/t on its Bullfrog Gold Project.

Bullfrog Gold announced in July 2017 the leasing of an additional 24 patented mining claims and the staking of 62 new mining claims at its Bullfrog Gold Project. The new lands may permit more expansions to the Montgomery-Shoshone (M-S) and Bullfrog open pit mines, have a number of worthy exploration targets, and provide more sites for heap leach pads and other project facilities.

This past August, Bullfrog Gold announced that Tetra Tech, Inc.'s NI 43-101 resource report on the Bullfrog Gold Project was posted on the website www.bullfroggold.com. The results of the report were released on June 27, 2017.

The results included measured and indicated (M&I) resource estimates of 525,000 ounces averaging 1.02 g/t using a gold price of $1200/oz and a base case cutoff grade of 0.36 g/t. Inferred resources were estimated at 120,000 ounces of gold averaging 1.20 g/t. The estimates are supported by a database, which includes 1,262 holes containing 155 miles of coring and drilling.

Bullfrog Gold Corp. (BFGC), closed Monday's trading session at $0.1099, up 1.24%, on 15,210 volume with 4 trades. The average volume for the last 60 days is 76,505 and the stock's 52-week low/high is $0.05/$0.18.


The QualityStocks
Company Corner


AV1 Group, Inc. (AVOP)

The QualityStocks Daily Newsletter would like to spotlight AV1 Group, Inc. (AVOP). Today, AV1 Group, Inc. closed trading at $0.0298, up 18.73%, on 27,684 volume with 9 trades. The stock’s average daily volume over the past 60 days is 67,652 and its 52-week low/high is $0.017/$0.28.

AV1 Group, Inc. (OTC: AVOP) recently announced the addition of Jon Fortune to its team. In a news release, AV1 Group CEO Bryen Beglinger stated, “We welcome Jon to our team. He has a wealth of experience and with his expertise in renewable energy, he will be a significant asset. He has a number of contacts in the industry that he is already working with on co-development opportunities, solutions and building customer relationships for our LED division and Smart City projects.”

AV1 Group, Inc. (AVOP), is a publicly traded investment and holding company established to identify, secure and monetize emerging growth companies in a number of sectors that include cannabis related technologies, grow houses and cultivation, and e-commerce businesses positioned for exponential growth. After identifying businesses displaying revolutionary concepts able to develop a substantial footprint in high-growth markets, the business model followed calls for incubating and supporting the best opportunities.

The company seeks to discover inspired entrepreneurs with innovative ideas that are poised for significant revenue generation. Management expertise can be seen in the development of embryonic-stage subsidiaries as the company brings a spectrum of backgrounds to the table with a significant resource of knowledge and experience to every venture. AV1 Group explores every opportunity to help each sector exceed its revenue goals while building close, active working relationships as it prepares each respective division to be a robust competitor within the various chosen markets.

AV1 Group companies include:

  • XFIRESmartSystems.com – Intelligent lighting solutions and wireless access for many different applications.
  • VaporHighUSA.com – Over 800 vaping products; bitcoin payments accepted.
  • DentalCannatizer.com – Revolutionary dual jet dental water jet integrates hemp oil infusing.
  • IntelligentLightingCorp.com – Comprehensive, energy-efficient lighting solutions.
  • CannaLighting.com – Wholly owned subsidiary building strategic relationships in the LED sector to provide solutions for grow houses and cultivation centers.
  • MJIQ – First, comprehensive, enterprise-grade integrated software suite being developed for the legal cannabis industry.
  • Hemptory.com – Engaging online destination for all hemp and cannabis related products and services.
  • Lawster.com – Puts consumers and small businesses in contact with legal services and service providers.
  • MJTestLabs.com – Under development website will serve cannabis dispensaries, laboratories and industry affiliates.

AV1 Group's business model delivers an advantage with internally-created projects that are poised for revenue generation and a cross-company revenue platform that enables the company to incubate and foster growth in early-stage subsidiaries under one umbrella. Disclaimer

AV1 Group, Inc. Blog

AV1 Group, Inc. News:

AV1 Group, Inc. (AVOP) Announces Engagement of Strategic Corporate Advisor to Assist in Propelling LED Division

AV1 Group Announces Engagement of Strategic Corporate Advisor to Assist in Propelling LED Division

NetworkNewsBreaks – AV1 Group, Inc.’s (AVOP) Smart Solutions Helping to Guide Modern Urban Development

MGX Minerals Inc. (MGXMF)

The QualityStocks Daily Newsletter would like to spotlight MGX Minerals Inc. (MGXMF). Today, MGX Minerals Inc. closed trading at $1.22, up 10.91%, on 370,890 volume with 140 trades. The stock’s average daily volume over the past 60 days is 289,426 and its 52-week low/high is $0.543/$1.5835.

MGX Minerals Inc. (CSE:XMG) (FKT:1MG) (OTCQB:MGXMF) is pleased to report the adsorbtion rate for the Company’s lithium extraction nanofiltration process (the “System”) has been increased from 20mg/g, milligram of lithium per gram of adsorbtion reagent, to an optimized 40mg/g Li/reagent. This reflects a doubling of adsorbtion rate and a significant cost cutting breakthrough as reagents reflect the single largest cost in the Company’s lithium extraction process.

MGX Minerals Inc. (CSE: XMG) (FKT: 1MG) (OTCQB: MGXMF) is a diversified Canadian resource company developing large-scale mineral portfolios in specific commodities and jurisdictions in North America. The company controls significant interest in lithium, magnesium and silicon assets that offer streamlined development timelines and low capital expenditures. MGX Minerals and its engineering partner have developed a patent-pending, low-energy design process to extract valuable minerals from the abundant, highly mineralized brine wastewater produced each year by oil and gas companies.

This proprietary, petrolithium process rapidly concentrates lithium and other minerals from brine in less than a day. That's a stunning advancement from the conventional method of extracting minerals from brine through an evaporation process that can take up to 18 months, requires hundreds of acres of land, and averages less than a 50 percent mineral recovery rate. Using this advanced water purification technology, MGX Minerals cleans the wastewater that accompanies petroleum as it's being pulled up to the surface. The company's petrolithium process eliminates the need to inject contaminated wastewater back into the ground, which prevents drinking water contamination and possible earthquakes.

In January 2017, MGX Minerals successfully recovered concentrated lithium from heavy oil evaporator blowdown wastewater using its rapid recovery process, an accomplishment independently confirmed by the Saskatchewan Research Council. In August 2017, the company also successfully processed wastewater and lithium brine from eight North American projects at its one-cubic-meter-per-hour processing plant, proving the technology is economically viable. Research group Global Water Intelligence expects the wastewater treatment industry to grow into a $45 billion market annually by 2025, which suggests there are ample revenue-generating opportunities for MGX Minerals technology.

Lithium, the "white gold" of the new energy economy, is the key to clean energy development as global demand for hybrid and electric vehicles, high-drain portable electronic devices, and large-scale energy storage systems ramps up. Grand View Research, Inc. reports that the global lithium-ion battery market is expected to reach $93.1 billion by 2025. Current market forces show a high demand for lithium and a low supply, which further supports the necessity of MGX Mineral's cleaner, faster method of extracting high-value minerals from brine wastewater.

MGX Minerals is led by a team of industry standout performers who have worked in the mining and technology industries for decades. The leadership team is joined by an array of top-notch technical partners with unmatched experience in the oil and gas sectors, environmental services industry, marketing and product development, along with applied research and commercial development of technologies. Disclaimer

MGX Minerals Inc. Blog

MGX Minerals Inc. News:

MGX Minerals Announces Advancement in Nanofiltration Lithium Technology; Commences Initial Design of 2400 Cubic Meter Per Day Plant

MGX Minerals Announces Publication and International Filing of Metal-Air Fuel Cell Patent; Eyes Mobile and Marine Applications

MGX Minerals Announces Acquisition of 20 Patents for Zinc Air Fuel Cell Battery

Skinvisible, Inc. (SKVI)

The QualityStocks Daily Newsletter would like to spotlight Skinvisible, Inc. (SKVI). Today, Skinvisible, Inc. closed trading at $0.025, up 9.65%, on 27,000 volume with 6 trades. The stock’s average daily volume over the past 60 days is 227,834 and its 52-week low/high is $0.02/$0.33.

It’s a simple phrase: “Wash your hands and use a hand sanitizer,” but doing it correctly and with the right product can make the difference when it comes to protection against a nasty bacteria or virus. Using an antiseptic hand sanitizer lotion such as DermSafe®, which incorporates Skinvisible’s (OTCQB: SKVI) proprietary Invisicare® drug delivery technology, is another vital tool offering a barrier against potentially serious illnesses.

Skinvisible, Inc. (SKVI) through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., is a Research and Development company whose patented Invisicare® technology can be used to revitalize or create new medical or skincare products, allowing a company that licenses Skinvisible's formulations to sell their own patented product and combat generic competitors.

A prescription dermatology product can generate $100 million or more a year, with the potential to lose 50-90% of that revenue when it goes off patent. Preserving that revenue is why the licensing of a product made with Invisicare is a very desirable option for many companies. The Company has developed a pipeline of 40 products using Invisicare, with a primary focus on optimizing the performance and increasing the value of "gold standard" dermatology drugs and licensing them to international and multi-national companies in the pharmaceutical, over-the-counter and cosmeceutical markets.

Invisicare® is a high performance topical and transdermal delivery system which enhances the delivery of drugs and other ingredients to and through the skin. The key to Skinvisible's patented technology and trademarked Invisicare® family of polymer delivery vehicles is its formula and process for combining hydrophilic and hydrophobic polymers into stable complexes in water emulsions. Invisicare® can be a key component of life cycle management, extending the life with a new patent-protected product, dramatically expanding the company's revenue stream.

Independent studies of Invisicare® have shown the following benefits:

  • Active ingredients stay on the skin for up to four hours or more and resist wash off and rub off.
  • Delivery method results in improved efficacy, reduced skin irritation and lower required dosage.
  • Unique formulations are non-drying and provide the ability to control the release of active ingredients.
  • Products form a protective barrier, which means normal skin respiration and perspiration occur and the product wears off as part of the skin's natural exfoliation process.

Terry Howlett, President, founder and CEO of Skinvisible Inc., said the Company has more than 15 years of scientific research and product development experience. All development is conducted using stringent pharmaceutical standards. The Company has licensed a number of its formulations including a prescription hemorrhoid cream in the USA, its anti-aging Kintari® line of products and DermSafe®, its non-alcohol hand sanitizer to a licensee in China. Producing licensed products for the booming cannabis industry is also an important element of the company's business strategy.

Skinvisible's foray into the rapidly expanding market for medicinal and recreational cannabis products is already underway with the development of the company's first hemp-derived CBD (cannabidiol) products. Skinvisible has negotiated an exclusive licensing deal in Canada with Canopy Growth Corporation, one of the world's leading cannabis companies. As part of the company's overall growth strategy, Skinvisible is also negotiating with a Licensed Producer in Las Vegas where Skinvisible scientists will develop THC (tetrahydrocannabinol) products for the legal recreational and medical marijuana market for the USA. Notably, Skinvisible is actively pursuing potential licensees through-out the world where medical cannabis is legal. These licensees will have the exclusive right to manufacture and distribute Skinvisible's cannabis products within their territory.

"We are excited about the results we are already seeing just with our hemp-derived CBD products," Howlett says. "Our science shows that our CBD products release almost four times that of market leaders and our transdermal product had an 81% penetration rate at 6 hours. These results are significant and provide the difference between ordinary cannabis products and ones enhanced by Invisicare."

The Company's business model includes out-licensing its formulations for a development fee, license fee and on-going royalties in addition to selling its Invisicare polymers to its licensees. Disclaimer

Skinvisible, Inc. Blog

Skinvisible, Inc. News:

Skinvisible, Inc. (SKVI) Products Can Offer Protection against Highly Contagious Viruses like H3N2

CannabisNewsBreaks – Skinvisible, Inc. (SKVI) Takes Aim at PTSD-related Suicides through Quoin Partnership

Skinvisible, Inc. (SKVI), Quoin Pharmaceuticals Proposed Merger to Address Opioid Pain Management Market

PotNetwork Holdings Inc. (POTN)

The QualityStocks Daily Newsletter would like to spotlight PotNetwork Holdings Inc. (POTN). Today, PotNetwork Holdings Inc. closed trading at $0.483, up 7.46%, on 7,136,599 volume with 1,581 trades. The stock’s average daily volume over the past 60 days is 12,755,989, and its 52-week low/high is $0.0006/$0.957.

PotNetwork Holding, Inc. (OTC: POTN) this morning announced the release of its unaudited financial statements for fiscal year 2017. Owing to the rapid growth of its wholly-owned Diamond CBD, Inc. subsidiary, PotNetwork achieved revenues of $14.5 million in calendar 2017.

PotNetwork Holdings Inc. (POTN), based in Fort Lauderdale, Florida, is a holding company. The company's First Capital Venture Co. subsidiary is the owner of Diamond CBD, Inc., a producer of widely-distributed CBD hemp extracts and the primary operating entity of PotNetwork Holdings.

Diamond CBD is made up of chemists and other scientists focused on developing and producing very high-quality CBD oil over a broad range of products, based upon a thorough understanding of the various natural molecules found in hemp and their particular properties. All products are made with federally legal cannabidiol (CBD), and are available in hundreds of flavors and sizes. The company emphasizes a dedication to 100% natural lab-tested CBD ingredients, with a carefully monitored process all the way from the source farm, through production, and final delivery to retail shelves.

PotNetwork, through Diamond CBD, delivers products to all 50 states, as well as internationally, and controls 15 CBD brands. The company lists the following product brands:

  • Diamond CBD Gummies - Diamond CBD branded edible gummies made from crystal isolate. Available in a variety of flavors and gummy styles, including rainbow bites, mini fruit, gummy worms, sour snakes, and more.
  • Chill Gummies - Chill gummies are more robust than its counterpart, the "Relax" gummy line. Chill Gummies are edible CBD gummies available in a wide variety of flavors, strengths, and styles including gummy bears, sour snakes, rainbow bites, watermelon slices, sour snakes, rainbow bites, peanut butter chocolate, ocean gummies, gummy worms, gummy rings and more.
  • CBD Liquid Gold - CBD Liquid Gold is derived from naturally grown industrial hemp plants, certified by USA labs and then carefully mixed with a patent-pending (non-PG) all-natural base formulation.
  • Blue CBD - Blue CBD Crystal Isolate is a high-end vapor liquid and oral drop infused with premium CBD rich hemp oil. CBD liquids are Premium Gold quality and test at a 7X higher concentration.
  • Relax Gummies - Relax Gummies give a lighter effect of CBD with some natural flavors in comparison to its counterpart Chill Gummies. Relax Gummies are perfect for anyone with a sweet tooth that's looking for a lighter effect without sacrificing quality or taste.
  • Premium Hemp Liquid Pet - CBD For Pets is a new and refreshing product from Diamond CBD for all the millions of pets out there. It is an organic product and also has unique flavors in it.
  • CBD Re-Leaf - Disposable, long-lasting, and ready to Use CBD Re-leaf vaping pens available in a variety of flavors. Easily take CBD anywhere on the go.
  • Relax Extreme CBD - Relax Extreme CBD Oil provides a high-quality, high-strength dose of CBD through oral drops. It is very easy to use and works instantly. Simply place a drop under the tongue. Available in various strengths.
  • CBD Double Shot - CBD Double Shots are specifically designed for one-time use. Easily squeeze the package in your mouth and swallow; it's that simple. Take it anywhere you go. Relaxation is now conveniently in your pocket. Drinkable CBD shots provide a quick boost of relaxation on the go. Available in various flavors.
  • Chill Pill - CBD infused capsules available in various strengths. Relax, take a Chill Pill.

Over 1.2 million people currently use cannabis, including CBD products, for medical application, including cancer, epilepsy, and depression. By sourcing hemp outside the U.S., the company avoids current federally-based legal problems involved in growing cannabis domestically. In the meantime, PotNetwork Holdings continues to target a large and rapidly developing cannabis market, expanding from $6.5 billion in 2016, to an expected $30 billion in 2021 (Forbes), and $50 billion in 2026 (Bloomberg). The cannabidiol market alone is projected to reach $2.1 billion in 2020, a 700% increase from 2015. PotNetwork Holdings Inc. plans to expand its subsidiaries as well as make strategic acquisitions. Disclaimer

PotNetwork Holdings Inc. Company Blog

PotNetwork Holdings Inc. News:

CannabisNewsBreaks – PotNetwork Holding, Inc. (POTN) Releases Unaudited Financial Statements for FY2017

CannabisNewsBreaks – PotNetwork Holding Inc. (POTN) Sales Drive Optimistic Share Price Target

Recent Report on PotNetwork Holding Inc. (POTN) Share Price Target Highlights Encouraging Data

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.0291, off by 0.85%, on 9,400,311 volume with 230 trades. The stock’s average daily volume over the past 60 days is 15,935,247, and its 52-week low/high is $0.0141/$0.16.

CannabisNewsAudio announces the Audio Press Release (APR) titled "Opportunity amid Cannabis Banking Hurdles," featuring Global Payout, Inc. (GOHE). To hear the NetworkNewsAudio version, visit: LINK. To read the original editorial, visit: LINK.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

CannabisNewsAudio Announces Audio Press Release (APR) on Innovators Honing Banking and Business Development Services for Cannabis Industry

CannabisNewsWire Announces Publication on Investment Opportunities as Companies Scale Cannabis Banking Roadblocks

Banking the Unbankable: MoneyTrac Technology, Inc. Aims to Bring Crypto to Cannabis

Lexaria Bioscience Corp. (CSE:LXX) (OTCQB:LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP). Today, Lexaria Bioscience Corp. closed trading at $1.51, off by 3.21%, on 167,687 volume with 271 trades. The stock’s average daily volume over the past 60 days is 491,424 and its 52-week low/high is $0.27/$2.54.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed DehydraTECH™, an oral digestion technology believed to improve the absorption rates of nicotine, non-steroid anti-inflammatory drugs (NSAIDs), vitamins and cannabinoids by as much as five to ten times the normal rate.

Lexaria Bioscience Corp. (LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body's gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria's products and others on the market is the company's disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the "unusual" taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company's technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria's processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government's National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria's unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience's business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company's patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria's lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world's most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria's revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company's growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets. Disclaimer

Lexaria Bioscience Corp. Blog

Lexaria Bioscience Corp. News:

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Expanding Best-in-Class Product Line

NetworkNewsAudio Announces Audio Press Release (APR) on Innovator Standouts Ahead of Canada's Recreational Cannabis

NetworkNewsWire Announces Publication on Canadian Cannabis Billions Finding Way to Innovators

ChineseInvestors.com, Inc. (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com, Inc. (CIIX). Today, ChineseInvestors.com, Inc. closed trading at $0.655, off by 5.07%, on 47,622 volume with 46 trades. The stock’s average daily volume over the past 60 days is 252,223 and its 52-week low/high is $0.40/$1.83.

NetworkNewsAudio announces the Audio Press Release (APR) titled "Hemp Provides Investors Access to Larger Cannabidiol Market," featuring ChineseInvestors.com (CIIX). To hear the NetworkNewsAudio version, visit: LINK. To read the original editorial, visit: LINK.

Founded in 1999, ChineseInvestors.com, Inc. (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com, Inc. Blog

ChineseInvestors.com, Inc. News

NetworkNewsAudio Announces Audio Press Release (APR) on Hemp Opportunities in Wide-Reaching Cannabidiol Market

NetworkNewsWire Announces Publication on HEMP Opportunities for Investors Looking in Wider Cannabidiol Space

Hemp Provides Investors Access to Larger Cannabidiol Market

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0639, off by 4.48%, on 5,756,129 volume with 359 trades. The stock’s average daily volume over the past 60 days is 14,321,982, and its 52-week low/high is $0.0132/$0.415.

NetworkNewsAudio announces the Audio Press Release (APR) titled "Consumers and Merchants Migrate into Cryptocurrencies in Next Market Evolution," featuring SinglePoint, Inc. (SING). To hear the NetworkNewsAudio version, visit: LINK. To read the original editorial, visit: LINK.

Singlepoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly-traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base.

SinglePoint's approach is to first research and identify acquisition opportunities in which it can take an active and influential role among existing leadership to provide enhanced strategy and direction. Target companies are undervalued, cash-flow positive, with high potential and verified assets. SinglePoint acquires and takes controlling interest of successful candidate companies.

SinglePoint recently signed a Letter of Intent to acquire an interest in Jacksam Corp., dba Convectium, a profitable California-based provider of equipment, branding, and packaging solutions for the cannabis industry. Convectium has developed the world's first cartridge and vape pen oil filling machine for wholesale distribution to dispensaries. The 710Shark and 710Seal systems can fill and package over 100 cartridges or disposable vape pens in 30 seconds and are sold to dispensaries through its EquipCanna.com brand. The company also operates a consumer brand that includes BlackoutX and HazeSticks and reaches customers in over 52 countries.

Additionally, SinglePoint has raised more than $300,000 and has signed a Letter of Intent to secure an additional $1 million in funding. The move provides management with ample capital to execute its business plan, while avoiding debt repayments that can eat into cash flow and reduce flexibility over time. It's also a rare development for a development-stage company in the cannabis industry.

Guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital, SinglePoint continues to explore high-potential acquisition opportunities to grow and diversify its current holding base. The company also plans to uplist to the OTCQB and become a fully reporting company during the current fiscal year.

The company has engaged Milost Advisors to pursue acquisitions and financing facilities toward funding acquisitions, as well as to provide working capital. Milost Advisors will assist SinglePoint in the acquisition of undervalued companies with annual revenues of at least $50 million, and has already identified potential acquisition targets for the company to consider. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

NetworkNewsAudio Announces Audio Press Release (APR) on Game Changers Leveraging Cryptocurrency Trend as it Gathers Steam

NetworkNewsWire Announces Publication on Cryptos Taking Front and Center Amid Market Evolution

SinglePoint Featured on MoneyTV with Donald Baillargeon, 2/9

RJD Green Inc. (RJDG)

The QualityStocks Daily Newsletter would like to spotlight RJD Green Inc. (RJDG). Today, RJD Green Inc. closed trading at $0.0226, up 32.94%, on 20,229,637 volume with 671 trades. The stock’s average daily volume over the past 60 days is 4,037,224, and its 52-week low/high is $0.006/$0.029.

RJD Green Inc. (RJDG) is a holding company with a focus on acquiring and managing assets and companies in three divisions. These initial high-growth enterprise opportunities offer diversity in separate recession resistant markets. The division holdings include:

  • RJD Green Healthcare Services – provides services to reduce cost and enhance management and operational capabilities in the healthcare sector.
  • Earthlinc Environmental Services – provides green environmental services and technologies.
  • Silex Holdings – acquires specialty construction and industrial manufacturing assets.

RJD Green Healthcare Services, through its wholly owned subsidiary IOSOFT Inc., provides proprietary software and IT support for medical billing, healthcare claims adjudication, and electronic payments between healthcare payers and providers. IOSOFT's unique payment technologies and services or software can be integrated with existing systems of healthcare payers such as Blue Cross, Aetna, CIGNA and others. IOSOFT provides targeted offerings for healthcare providers, provider networks, physicians and hospitals, and clearinghouse companies.

Earthlinc Environmental Solutions was formed to bring forward green-applied technologies and offer environmental services with a focus on North America. The division's first acquisition, Animal Waste Management, is launching operations of a patented, fully developed technology for processing waste produced on commercial poultry and hog farms. Development of this technology was supported by the University of Arkansas and the Missouri Department of Natural Resources. This important technology improves the farm's productivity and is competitively priced with the current expense of handling waste removal at these sites.

The company's third division – Silex Holdings Inc. – was formed to acquire and manage high-growth assets and business enterprises in the industrial and construction specialty services sectors. With its first acquisition of Silex Interiors, a manufacturer, distributor and installer of counter tops, cabinets and related kitchen and bath products, the division is poised to expand into major national markets through internal expansion, acquisition and franchising. The company is modeled to operate a minimum of four corporately owned locations with 12 to 18 franchise locations nationwide.

RJD Green seeks to participate as owners, partners or in joint ventures in a wide range of business enterprises. The company's goal of creating a successful, enjoyable business enterprise for its company team and staff, along with its business partners and investors, is paired with the goal of maximizing the business potential of the enterprise by enhancing profits and the quality of the company. Disclaimer

RJD Green Inc. Company Blog

RJD Green Inc. News:

RJD Green Inc. appoints Mr. Jerry Niblett as Chief Operating Officer

RJD Green, Inc. Announces Earthlinc Environmental Services Launches New Division

RJD Green Inc. Recaps 2017 10K Filing and Expected 2018 Events


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



Trader Power News
(DARE) +50.00%


(AQMS) +35.80%


(FNJN) +35.59%

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251